back from tokyo, page-4

Interesting point you've brought up Primatron, while Biomira did not elect ( for what whatever reason, perhaps because their strategic alignment is no longer in this field) they have not by the sounds of things sold their stake in Prima. Also as far as I am aware the sell down you predicted by major shareholder QIC has not eventuated.
I am no longer a shareholder essentially because while I was comfortable with the science I lost confidence with the management. I believe if this company had good management and market credibility it would be a different company today. While a long shot it is still not beyond the odds that they could prosper so I retain an open mind.